Amarantus Bioscience Holdings Inc (AMBS)

[MUKA1]

The new results DO provide new information…although slight.

Unless I’m missing something, the new data was derived from a neuro-protective study...MANF administered, and then damage induced.

Previous data was from a neuro-restorative study...damage induced, and then MANF administered.

Not saying I wouldn’t be happier with a bigger PR about JV, but this is in fact new study data that could imply usage of MANF as both a reactive and proactive treatment.